Paclitaxel Injection, Solution
Product Images NDC 16714-137

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 16714-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

300mg-carton (Carton Label)

300mg-carton (Carton Label)
Packaging label for Paclitaxel Injection, USP 6 mg/mL, 300 mg/50 mL multiple dose vial by Northstar Rx LLC. The label indicates it is a semisynthetic injection, with warnings including cytotoxic agent caution and dilution required prior to intravenous infusion. Storage instructions specify 20° to 25°C and protection from light. Manufactured by MSN Laboratories in India.*
FDA Label Image

Fig-1 (Figure 1)

Fig-1 (Figure 1)
A Kaplan-Meier survival curve chart showing proportion surviving over a period of up to 5 years, comparing two groups labeled Cc and Tc. The graph includes the number at risk for both groups at yearly intervals, number of events, and a hazard ratio with 95% confidence interval, illustrating survival differences between the groups over time.*
FDA Label Image

Fig-2 (Figure 2)

Fig-2 (Figure 2)
A survival curve graph comparing the proportion surviving over years between two groups labeled Cc and Tc. The graph includes a legend with sample sizes, number of events, and hazard ratio with confidence interval. The x-axis represents years from 0 to 5, and the y-axis shows the proportion surviving from 0.0 to 1.0.*
FDA Label Image

Fig-3 (Figure 3)

Fig-3 (Figure 3)
A Kaplan-Meier survival curve showing the proportion of patients disease-free over 4 years comparing two treatment groups labeled AC and AC+T. The y-axis represents the proportion disease-free from 0.2 to 1, and the x-axis shows time in years from 0 to 4. The chart includes a table with the number of patients at risk, number of events, hazard ratio, and confidence interval for each group.*
FDA Label Image

Fig-4 (Figure 4)

Fig-4 (Figure 4)
A survival curve graph depicting the proportion surviving over four years comparing two groups labeled AC and AC+T. The x-axis represents years, and the y-axis shows the proportion surviving from 0 to 1. The graph includes a table with clinical data such as number of events, hazard ratio (HR), and confidence intervals (CI) for each group, along with the number of patients at risk at various time points.*
FDA Label Image

Fig-5 (Figure 5)

Fig-5 (Figure 5)
A Kaplan-Meier survival curve chart showing the proportion of patients disease-free over a 4-year period. The chart compares two groups labeled AC and AC+T, with corresponding survival curves illustrating differences in disease-free survival rates over time. An inset table provides numerical data including sample sizes, number of events, hazard ratio, confidence interval, and number of patients at risk at different time points.*
FDA Label Image

Fig-6 (Figure 6)

Fig-6 (Figure 6)
A Kaplan-Meier curve depicting the proportion of patients remaining disease-free over approximately 4 years, comparing two treatment groups labeled AC and AC+T. The graph includes a table of events, hazard ratio, and numbers at risk over time for each group.*
FDA Label Image

Fig-7 (Figure 7)

Fig-7 (Figure 7)
A Kaplan-Meier survival curve showing the proportion of patients disease-free over a period of 4 years. Two treatment groups, labeled AC and AC+T, are compared with lines indicating their respective disease-free proportions. The chart includes a table with numbers of patients at risk, number of events, hazard ratio (HR), and 95% confidence intervals (CI) for each group.*
FDA Label Image

Fig-8 (Figure 8)

Fig-8 (Figure 8)
A Kaplan-Meier survival curve showing the proportion of patients disease free over time in years. Two groups are compared: AC and AC+T, with corresponding numbers at risk, events, and hazard ratio with confidence intervals detailed in an inset table.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of paclitaxel, displaying its molecular arrangement with multiple rings and functional groups formed by carbon, hydrogen, oxygen, and nitrogen atoms.*
FDA Label Image

300mg-vial (Vial Label)

300mg-vial (Vial Label)
Label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) solution for intravenous injection. The product is a cytotoxic agent in a 50 mL multiple dose vial. Manufactured for Northstar Rx LLC and by MSN Laboratories Private Limited, India. Label includes caution for dilution prior to infusion, handling instructions, storage conditions, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.